secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeueHealth, Inc. (—)
CIK:        0001671284
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001671284-24-000032
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeueHealth Q1 net income $5.7M vs loss of $53.9M YoY; adj. EBITDA $2.5M; revenue $245M
--------------------------------------------------------------------------------

- Revenue of $245.1M, down 18% YoY from $300.6M; net income from continuing ops of $5.7M vs loss of $53.9M.
- Adjusted EBITDA of $2.5M in Q1’24 vs negative $5.7M YoY; 2024 adj. EBITDA guidance maintained at $15-25M.
- Value-Based Consumers served 360,000 (down 3.5% YoY); Enablement Services Lives surged to 109,000 from 27,000.
- 2014 full-year revenue guidance ~$1B with NeueCare segment $310-320M and NeueSolutions $690-700M.
- Adjusted Operating Cost Ratio guided at 15-16% (ex-corporate) and 19-20% (inclusive) for 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671284/000167128424000032/0001671284-24-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671284/000167128424000032/bhg-20240508.htm
  HTML page:      https://secwatch.observer/filing/0001671284-24-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer